Early tranexamic acid administration: A protective effect on gut barrier function following ischemia/reperfusion injury

Journal of Trauma and Acute Care Surgery

Volumn 79, Issue 6, 2015, Pages 1015-1022

  Diebel, Mark E ^a   Diebel, Lawrence N ^a   Manke, Charles W ^b   Liberati, David M ^a   Whittaker, John R ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Wayne State University   (United States)

Author keywords

Caco 2 cells; HT29 MTX cells; mucus barrier; Tranexamic acid

Indexed keywords

DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; TRANEXAMIC ACID; TRYPSIN; MALONALDEHYDE;

APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; COCULTURE; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DIGESTIVE TRACT PARAMETERS; DISEASE SEVERITY; DRUG TRANSPORT; FLOW CYTOMETRY; FLOW KINETICS; GUT BARRIER FAILURE; HEMORRHAGIC SHOCK; HT 29 CELL LINE; HYPOXIA; IN VITRO STUDY; INTESTINAL MUCUS DEGRADATION; INTESTINAL MUCUS THICKNESS; INTESTINE CELL; INTESTINE FUNCTION; INTETSINAL MUCUS VISCOSITY; LIPID PEROXIDATION; MONOLAYER CULTURE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; PROTEIN CARBONYLATION; REOXYGENATION; REPERFUSION INJURY; TRANSEPITHELIAL ELECTRICAL RESISTANCE; DRUG EFFECTS; HUMAN; INTESTINE MUCOSA; METABOLISM; MUCUS; VISCOSITY;

APOPTOSIS; CACO-2 CELLS; COCULTURE TECHNIQUES; FLOW CYTOMETRY; HUMANS; IN VITRO TECHNIQUES; INTESTINAL MUCOSA; MALONDIALDEHYDE; MUCUS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; REPERFUSION INJURY; RHEOLOGY; TRANEXAMIC ACID; VISCOSITY;

EID: 84948961687     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0000000000000703     Document Type: Article

References (30)

1. Qin X, Sheth SU, Sharpe SM, Dong W, Lu Q, Xu D, Deitch EA,. The mucus layer is critical in protecting against ischemia/reperfusion-mediated gut injury and in the restitution of gut barrier function. Shock. 2011; 35: 275-281.
2. Fishman JE, Sheth SU, Levy G, Alli V, Lu Q, Xu D, Qin Y, Deitch EA,. Intraluminal nonbacterial intestinal components control gut and lung injury after trauma hemorrhagic shock. Ann Surg. 2014; 260: 1112-1120.
3. Schmid-Schonbein GW,. Inflammation and the autodigestion hypothesis. Microcirculation. 2009; 16: 289-306.
4. Chang M, Kistler EB, Schmid-Schonbein GW,. Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall. Shock. 2012; 37: 297-305.
5. Chang M, Alsaigh T, Kistler EB, Schmid-Schoenbein GW,. Breakdown of mucin as barrier to digestive enzymes in the ischemic rat small intestine. PLoS One. 2012; 7: e40087.
6. Altshuler AE, Lamadrid I, Li D, Ma SR, Kurre L, Scmid-Schoenbein GW, Penn AH,. Transmural intestinal wall permeability in severe ischemia after enteral protease inhibition. PLoS One. 2014; 9: e96655.
7. Deitch EA, Shi HP, Lu Q, Feketeova E, Xu DZ,. Serine proteases are involved in the pathogenesis of trauma-hemorrhagic shock-induced gut and lung injury. Shock. 2003; 19: 452-456.
8. Dunn CJ, Goa KL,. Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999; 57: 1005-1032.
9. CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, Dewan Y, El-Sayed H, Hunt B, Gupta S, Herrera J, Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376: 23-32.
10. Morrison J, Dubose J, Rasmussen T, Midwinter M,. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012; 147: 113-119.
11. Jimenez JJ, Iribarren JL, Lorento L, Rodriguez JM, Hernandez D, Nassar I, Perez R, Brouard M, Milena A, Martinez R, Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial. Crit Care. 2007; 11: R117.
12. Diebel ME, Diebel LN, Manke CW, Liberati DM,. Estrogen modulates intestinal mucus physiochemical properties and protects against oxidant injury. J Trauma Acute Care Surg. 2015; 78: 94-99.
13. Ansari TM, Raza A, Rehman A,. Spectrophotometric determination of tranexamic acid in pharmaceutical bulk and dosage forms. Anal Sci. 2005; 21: 1133-1135.
14. Cone RA,. Barrier properties of mucus. Adv Drug Deliv Rev. 2009; 61: 75-85.
15. Pelaseyed T, Bergstrom JH, Gustafsson JK, Ermund A, Birchenough GM, Schutte A, van der Post S, Svensson F, Wising C, Nystrom EE, The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014; 260: 8-20.
16. Ermund A, Schutte A, Johansson ME, Gustaffson JK, Hansson GC,. Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches. Am J Physiol Gastrointest Liver Physiol. 2013; 305: G341-G347.
17. Rupani B, Caputo FJ, Watkins AC, Vega D, Magnotti LJ, Lu Q, Xu da Z, Deitch EA,. Relationship between disruption of the unstirred mucus layer and intestinal restitution in loss of gut barrier function after trauma hemorrhagic shock. Surgery. 2007; 141: 481-489.
18. Lu Q, Xu DZ, Sharpe S, Doucet D, Pisarenko V, Lee M, Deitch EA,. The anatomic sites of disruption of the mucus layer directly correlate with areas of trauma/hemorrhagic shock-induced gut injury. J Trauma. 2011; 70: 630-635.
19. Sellers LA, Allen A, Morris ER, Ross-Murphy SB,. The rheology of pig small intestinal and colonic mucus: weakening of gel structure by non-mucin components. Biochim Biophys Acta. 1991; 1115: 174-179.
20. Grisham MB, Von Ritter C, Smith BF, Lamont JT, Granger DN,. Interaction between oxygen radicals and gastric mucin. Am J Physiol. 1987; 253: G93-G96.
21. Brownlee IA, Knight J, Dettmar PW, Pearson JP,. Action of reactive oxygen species on colonic mucus secretions. Free Radic Biol Med. 2007; 43: 800-808.
22. Bounous G, McArdle AH, Hodges DM, Hampson LG, Gurd FN,. Biosynthesis of intestinal mucin in shock: relationship to tryptic hemorrhagic enteritis and permeability to curare. Ann Surg. 1965; 164: 13-22.
23. Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetusso L, Gasbarrini A,. The gut barrier: New acquisitions and therapeutic approaches. J Clin Gastroenterol. 2012; 46: S12-S17.
24. Walter E, Janich S, Roessler BJ, Hilfinger JM, Amidon GL,. HT29-MTX/Caco-2 co cultures as an in vitro model for the intestinal epithelium: in vitro-in vivo correlation with permeability data from rats and humans. J Pharm Sci. 1996; 85: 1070-1076.
25. Pontier C, Pachot J, Botham R, Lenfant B, Arnaud P,. HT29-MTX and Caco-2/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer. J Pharm Sci. 2001; 90: 1608-1619.
26. Cole E, Davenport R, Willett K, Brohi K,. Tranexamic acid use in severely injured civilian patients and the effects on outcomes. A prospective cohort study. Ann Surg. 2015; 261: 390-394.
27. Medina C, Radomski MW,. Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther. 2006; 318: 933-938.
28. Grassin-Delyle S, Tremey B, Abe E, Fischler M, Alvarez JC, Devillier P, Urien S,. Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Br J Anaesth. 2013; 111: 916-924.
29. Fiechtner BK, Nuttall GA, Johnson ME, Dong Y, Sujirattanawimol N, Oliver WC Jr, Sarpal RS, Oyen LJ, Ereth MH,. Plasma tranexamic acid concentrations during cardiopulmonary bypass. Anesth Analg. 2001; 92: 1131-1136.
30. Pusateri AE, Weiskopf RB, Bebarta V, Butler F, Cestero RF, Chaudry IH, Deal V, Dorlac WC, Gerhardt RT, Given MB, Tranexamic acid and trauma: current status and knowledge gaps with recommended research priorities. Shock. 2013; 39: 121-126.